Literature DB >> 1570342

A genetic system for studying the activity of a proteolytic enzyme.

B Dasmahapatra1, B DiDomenico, S Dwyer, J Ma, I Sadowski, J Schwartz.   

Abstract

We describe a genetic system for monitoring the activity of a specific proteolytic enzyme by taking advantage of the properties of the yeast transcriptional activator GAL4. The GAL4 protein contains two separable and functionally essential domains: the amino-terminal DNA binding domain and the carboxyl-terminal transcriptional activating domain. We constructed two hybrid proteins by inserting between the DNA binding domain and the activation domain of GAL4 either (i) a self-cleaving protease (3C protease of a picornavirus, coxsackievirus B3) or (ii) a mutant form of the protease that is unable to cleave. We show that, although the hybrid protein containing the mutant protease activates transcription of GAL1-lacZ reporter gene, the hybrid protein bearing the wild-type protease is proteolytically cleaved and fails to activate transcription. Our approach to monitor the proteolytic activity could be used to develop simple genetic systems to study other proteases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1570342      PMCID: PMC525652          DOI: 10.1073/pnas.89.9.4159

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Complete mutagenesis of the HIV-1 protease.

Authors:  D D Loeb; R Swanstrom; L Everitt; M Manchester; S E Stamper; C A Hutchison
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

2.  Chemical synthesis and expression of the HIV-1 protease gene in E. coli.

Authors:  J M Louis; E M Wondrak; T D Copeland; C A Smith; P T Mora; S Oroszlan
Journal:  Biochem Biophys Res Commun       Date:  1989-02-28       Impact factor: 3.575

Review 3.  Extralysosomal protein degradation.

Authors:  S Pontremoli; E Melloni
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

4.  Direct selection for sequences encoding proteases of known specificity.

Authors:  T A Smith; B D Kohorn
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  GAL4 activates gene expression in mammalian cells.

Authors:  H Kakidani; M Ptashne
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

6.  Encephalomyocarditis virus 3C protease: efficient cell-free expression from clones which link viral 5' noncoding sequences to the P3 region.

Authors:  G D Parks; G M Duke; A C Palmenberg
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  The Epstein-Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1 5' long terminal repeat.

Authors:  R Mallon; J Borkowski; R Albin; S Pepitoni; J Schwartz; E Kieff
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Cell-free expression of the coxsackievirus 3C protease using the translational initiation signal of an insect virus RNA and its characterization.

Authors:  B Dasmahapatra; E J Rozhon; A M Hart; S Cox; S Tracy; J Schwartz
Journal:  Virus Res       Date:  1991-08       Impact factor: 3.303

9.  Transformation of intact yeast cells treated with alkali cations.

Authors:  H Ito; Y Fukuda; K Murata; A Kimura
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

10.  GAL4 is phosphorylated as a consequence of transcriptional activation.

Authors:  I Sadowski; D Niedbala; K Wood; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

View more
  9 in total

1.  Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli.

Authors:  N Dautin; G Karimova; A Ullmann; D Ladant
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

2.  Cell-based Assays to Identify Inhibitors of Viral Disease.

Authors:  Neil Green; Robert D Ott; Richard J Isaacs; Hong Fang
Journal:  Expert Opin Drug Discov       Date:  2008-06-01       Impact factor: 6.098

Review 3.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

Review 4.  The picornaviral 3C proteinases: cysteine nucleophiles in serine proteinase folds.

Authors:  B A Malcolm
Journal:  Protein Sci       Date:  1995-08       Impact factor: 6.725

5.  A yeast-based growth assay for the analysis of site-specific proteases.

Authors:  Fabian Köhler
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

6.  An assay to monitor HIV-1 protease activity for the identification of novel inhibitors in T-cells.

Authors:  Brett J Hilton; Roland Wolkowicz
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

7.  Model system for high-throughput screening of novel human immunodeficiency virus protease inhibitors in Escherichia coli.

Authors:  Ting-Jen Cheng; Ashraf Brik; Chi-Huey Wong; Chen-Chen Kan
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

8.  A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity.

Authors:  Bingqing Li; Yingying Yue; Yajie Zhang; Zenglin Yuan; Peng Li; Nannan Song; Wei Lin; Yan Liu; Lichuan Gu; Hong Meng
Journal:  Front Cell Infect Microbiol       Date:  2017-02-03       Impact factor: 5.293

Review 9.  In vitro methods for testing antiviral drugs.

Authors:  Michaela Rumlová; Tomáš Ruml
Journal:  Biotechnol Adv       Date:  2017-12-29       Impact factor: 14.227

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.